Investments

RevBio receives a $2.2 million phase II NIH grant to further develop the minimally invasive use of TETRANITE to treat...

This new funding will fuel Spineart’s next phase of profitable growth, enabling the company to advance its innovation pipeline and...

We look at the recent initial public offerings by Carlsmed and Shoulder Innovations, the first orthopedic IPOs in a number...

Under the agreement, Partners Group will acquire a significant minority stake in restor3d and provide $65 million of new equity....

The funding will accelerate ODI’s development of a fully integrated imaging platform for orthopedic surgery....

Funds will support development of the company's novel therapies for periprosthetic joint infection, a complication of joint replacement procedures....

Proceeds will primarily support continued commercialization of the company's implants for total and reverse total shoulder arthroplasty, as well as...

Carlsmed is a commercial-stage medical technology company offering artificial intelligence-enabled personalized spine surgery solutions....

The company offers implant systems for shoulder arthroplasty, as well as enabling technologies, instrument systems, support and surgeon-to-surgeon collaboration....

The company has developed a device to remove surgical cement during hip joint revision procedures....